August 30, 2019
MOROI NAMED CHAIR OF OPHTHALMOLOGY AND VISUAL SCIENCE AT OHIO STATE
Dr. Sayoko (Sy) Moroi has been named chair of the Department of Ophthalmology and Visual Science at The Ohio State University College of Medicine. Dr. Moroi comes to Ohio State from the University of Michigan, where she is the Jerome Jacobson Professor of Ophthalmology and Visual Sciences, chief of the Division of Glaucoma and director of the Glaucoma Fellowship. She will join the Ohio State team in January 2020. A nationally recognized academic clinician and physician-scientist, Dr. Moroi focuses on precision medicine, an individualized approach toward prevention and treatment of glaucoma. At the University of Michigan, one of the nation’s leading departments of ophthalmology, Dr. Moroi has strategically grown the number of faculty across sub-specialties to transform their care model to a collaborative co-management system. She has received multiple awards and invited lectureships, including the 2018 Robert N. Shaffer Lecture, which the American Academy of Ophthalmology awards to only one individual each year.
OHIO STATE AWARDED $1.9 MILLION GRANT FOR RETINAL DETACHMENT RECOVERY RESEARCH
Dr. Colleen Cebulla, associate professor of ophthalmology at The Ohio State University Wexner Medical Center, has been awarded a $1.9 million grant from the Department of Defense for retinal detachment recovery research. Proliferative vitreoretinopathy (PVR) is the most common cause of failure of retinal detachment surgery, occurs frequently after retinal trauma, and there are no effective pharmaceuticals to prevent it. The study is investigating the effects of drugs that target macrophage migration inhibitory factor (MIF), which is produced at high levels in PVR, as well as testing the ability of different clinically relevant MIF inhibitors to block photoreceptor death and abnormal healing. Cebulla and her team, as well as Andy Fischer, professor of neuroscience, Abhay Satoskar, professor of pathology, and Julie Racine, director of visual electrophysiology at Nationwide Children’s Hospital, will look for other clinically-relevant MIF inhibitors to determine if they would potentially be helpful for traumatic retinal detachments that military personnel might experience.
$1.1 MILLION GRANT FURTHERS VACCINE RESEARCH FOR NEGLECTED TROPICAL DISEASE
The Global Health Innovation Technology Fund has awarded a $1.1 million grant towards the development a vaccine for Chagas disease to an infectious disease researcher at The Ohio State University College of Medicine. Dr. Bradford McGwire, an associate professor of infectious disease, will lead an international team focused on re-engineering and testing a Chagas disease vaccine in preparation for future animal and human trials. The ultimate goal is to create a vaccine to prevent Chagas disease in humans and reservoir animals. Chagas disease, spread by the kissing bug, can cause heart problems that can be fatal. Dr. McGwire is collaborating with researchers at Ohio University, Pontifical Catholic University of Ecuador and Nagasaki University in Japan.
DEAN KENT NAMED CHAIR OF AMERICAN BOARD OF SURGERY
Dr. K. Craig Kent, dean of The Ohio State University College of Medicine, has been named chair of the American Board of Surgery for 2019 – 2020. ABS is the national certifying body for general surgeons and related specialists. Dr. Kent is a vascular surgeon with an emphasis in carotid and aortic interventions. As an academic physician and clinical leader, he has held numerous leadership positions in surgery organizations including past president of the Society for Vascular Surgery, chair of the NIH: NHLBI Bioengineering, Technology and Surgical Sciences Study Section, and past president of the Society of Surgical Chairs. Dr. Kent has authored more than 325 articles and 65 book chapters and has served on the editorial boards of multiple medical journals.
CYSTIC FIBROSIS RESEARCH AND DEVELOPMENT PROGRAM AWARDED $2 MILLION GRANT
The Cystic Fibrosis Foundation awarded a team of researchers at The Ohio State University College of Medicine and Nationwide Children’s Hospital a $2 million grant over four years to continue development of the Cure CF Columbus Research and Development Program (C3 RDP). The program aims to study the relationship between immune system function and cystic fibrosis to develop treatments that will improve clinical outcomes for children and adults with CF. The C3 RDP is co-directed by Karen McCoy, MD, professor of Pediatrics at the College of Medicine and chief of Pulmonary Medicine at Nationwide Children’s, and Daniel Wozniak, professor of Microbiology and Microbial Infection and Immunity at the College of Medicine.
OHIO STATE NAMED CENTER OF EXCELLENCE FOR ANTIMICROBIAL STEWARDSHIP
The Ohio State University Wexner Medical Center has been awarded the designation of Antimicrobial Stewardship Center of Excellence (CoE) by The Infectious Diseases Society of America (ISDA). The CoE program recognizes institutions that have created stewardship programs led by infectious diseases physicians and ID-trained pharmacists that are of the highest quality and have achieved standards aligned with evidence-based national guidelines such as the IDSA-SHEA guidelines and the Centers for Disease Control and Prevention’s Core Elements. A total of 64 programs nationwide have received the designation since the program’s launch in 2017.
BOGNER RECEIVES NATIONAL AWARD FOR TRAUMATIC BRAIN INJURY RESEARCH
The Brain Injury Association of America has awarded the William Fields Caveness Award to Jennifer Bogner for her research and outstanding contributions on both a national and international level to improve the lives of those who have sustained a brain injury. Bogner is a professor at The Ohio State University Wexner Medical Center Department of Physical Medicine and Rehabilitation. Her research focuses on behavioral and emotional regulation, substance misuse, community participation and the long-term effects of traumatic brain injury. Read more.
###
Media Contact: Alexis Shaw, Wexner Medical Center Public Affairs and Media Relations, 614-293-3737, Alexis.Shaw2@osumc.edu
Dr. Sayoko (Sy) Moroi has been named chair of the Department of Ophthalmology and Visual Science at The Ohio State University College of Medicine. Dr. Moroi comes to Ohio State from the University of Michigan, where she is the Jerome Jacobson Professor of Ophthalmology and Visual Sciences, chief of the Division of Glaucoma and director of the Glaucoma Fellowship. She will join the Ohio State team in January 2020. A nationally recognized academic clinician and physician-scientist, Dr. Moroi focuses on precision medicine, an individualized approach toward prevention and treatment of glaucoma. At the University of Michigan, one of the nation’s leading departments of ophthalmology, Dr. Moroi has strategically grown the number of faculty across sub-specialties to transform their care model to a collaborative co-management system. She has received multiple awards and invited lectureships, including the 2018 Robert N. Shaffer Lecture, which the American Academy of Ophthalmology awards to only one individual each year.
OHIO STATE AWARDED $1.9 MILLION GRANT FOR RETINAL DETACHMENT RECOVERY RESEARCH
Dr. Colleen Cebulla, associate professor of ophthalmology at The Ohio State University Wexner Medical Center, has been awarded a $1.9 million grant from the Department of Defense for retinal detachment recovery research. Proliferative vitreoretinopathy (PVR) is the most common cause of failure of retinal detachment surgery, occurs frequently after retinal trauma, and there are no effective pharmaceuticals to prevent it. The study is investigating the effects of drugs that target macrophage migration inhibitory factor (MIF), which is produced at high levels in PVR, as well as testing the ability of different clinically relevant MIF inhibitors to block photoreceptor death and abnormal healing. Cebulla and her team, as well as Andy Fischer, professor of neuroscience, Abhay Satoskar, professor of pathology, and Julie Racine, director of visual electrophysiology at Nationwide Children’s Hospital, will look for other clinically-relevant MIF inhibitors to determine if they would potentially be helpful for traumatic retinal detachments that military personnel might experience.
$1.1 MILLION GRANT FURTHERS VACCINE RESEARCH FOR NEGLECTED TROPICAL DISEASE
The Global Health Innovation Technology Fund has awarded a $1.1 million grant towards the development a vaccine for Chagas disease to an infectious disease researcher at The Ohio State University College of Medicine. Dr. Bradford McGwire, an associate professor of infectious disease, will lead an international team focused on re-engineering and testing a Chagas disease vaccine in preparation for future animal and human trials. The ultimate goal is to create a vaccine to prevent Chagas disease in humans and reservoir animals. Chagas disease, spread by the kissing bug, can cause heart problems that can be fatal. Dr. McGwire is collaborating with researchers at Ohio University, Pontifical Catholic University of Ecuador and Nagasaki University in Japan.
DEAN KENT NAMED CHAIR OF AMERICAN BOARD OF SURGERY
Dr. K. Craig Kent, dean of The Ohio State University College of Medicine, has been named chair of the American Board of Surgery for 2019 – 2020. ABS is the national certifying body for general surgeons and related specialists. Dr. Kent is a vascular surgeon with an emphasis in carotid and aortic interventions. As an academic physician and clinical leader, he has held numerous leadership positions in surgery organizations including past president of the Society for Vascular Surgery, chair of the NIH: NHLBI Bioengineering, Technology and Surgical Sciences Study Section, and past president of the Society of Surgical Chairs. Dr. Kent has authored more than 325 articles and 65 book chapters and has served on the editorial boards of multiple medical journals.
CYSTIC FIBROSIS RESEARCH AND DEVELOPMENT PROGRAM AWARDED $2 MILLION GRANT
The Cystic Fibrosis Foundation awarded a team of researchers at The Ohio State University College of Medicine and Nationwide Children’s Hospital a $2 million grant over four years to continue development of the Cure CF Columbus Research and Development Program (C3 RDP). The program aims to study the relationship between immune system function and cystic fibrosis to develop treatments that will improve clinical outcomes for children and adults with CF. The C3 RDP is co-directed by Karen McCoy, MD, professor of Pediatrics at the College of Medicine and chief of Pulmonary Medicine at Nationwide Children’s, and Daniel Wozniak, professor of Microbiology and Microbial Infection and Immunity at the College of Medicine.
OHIO STATE NAMED CENTER OF EXCELLENCE FOR ANTIMICROBIAL STEWARDSHIP
The Ohio State University Wexner Medical Center has been awarded the designation of Antimicrobial Stewardship Center of Excellence (CoE) by The Infectious Diseases Society of America (ISDA). The CoE program recognizes institutions that have created stewardship programs led by infectious diseases physicians and ID-trained pharmacists that are of the highest quality and have achieved standards aligned with evidence-based national guidelines such as the IDSA-SHEA guidelines and the Centers for Disease Control and Prevention’s Core Elements. A total of 64 programs nationwide have received the designation since the program’s launch in 2017.
BOGNER RECEIVES NATIONAL AWARD FOR TRAUMATIC BRAIN INJURY RESEARCH
The Brain Injury Association of America has awarded the William Fields Caveness Award to Jennifer Bogner for her research and outstanding contributions on both a national and international level to improve the lives of those who have sustained a brain injury. Bogner is a professor at The Ohio State University Wexner Medical Center Department of Physical Medicine and Rehabilitation. Her research focuses on behavioral and emotional regulation, substance misuse, community participation and the long-term effects of traumatic brain injury. Read more.
###
Media Contact: Alexis Shaw, Wexner Medical Center Public Affairs and Media Relations, 614-293-3737, Alexis.Shaw2@osumc.edu